Pharmaceuticals and Global Health:
Inequalities and Innovation in the 21st Century
19 July 2013
University of Sussex Conference Centre
Brighton, United Kingdom
Programme
9:30 –10:00
Arrival and registration
10:00 – 10:15
Opening remarks:
Professor Stefan Elbe, Director, Centre for Global Health Policy
Professor Melanie Newport, Brighton and Sussex Medical School
10:15 – 11:15
Keynote Lecture:
Professor Vinh-Kim Nguyen, University of Montreal
‘Eradication: the science and politics of a “world without AIDS”’
Chair: Dr Alvaro Bermejo, Executive Director of International HIV/AIDS Alliance
and Board Member of the Global Fund
11:15 – 12:45
Plenary Panel: Pharmaceuticals and Global Health: Successes, Challenges and
Outlook
Chair: Professor Stefan Elbe, Director, Centre for Global Health Policy
Discussant: Professor Melanie Newport, Brighton and Sussex Medical School
Speakers:
Dr Manica Balasegaram, Executive Director of MSF’s Access Campaign
Thomas Cueni, Director-General, Interpharma
Dr Brian Tempest, former CEO of Ranbaxy, Chairman Hale & Tempest Co Ltd
Dr Krisantha Weerasuriya, Secretary, Expert Committee on Selection and Use of
Essential Medicines, World Health Organization
Dr Kalipso Chalkidou, Director, NICE International
1
12:45 – 1:45
Lunch
1:45 – 3:15
Concurrent Panel Session:
Panel 1. The Pharmaceutical Industry and Global Health: Emerging Models of
Pharmaceutical Development and Production
Chair: Professor Huw Taylor, University of Brighton
Discussant: Professor Pete Clifton, University of Sussex
Speakers:
Professor Paul Nightingale, Science and Technology Policy Research, University of
Sussex
Professor Simon Ward, Director, Translational Drug Discovery Group, University of
Sussex
Lindsey Wu, Senior Analyst, Policy Cures
Dr Giuliano Russo, Instituto de Higiene e Medicina Tropical (Lisbon/ Portugal) and
Sussex/IDS
Rachelle Harris, Policy Adviser, Access to Medicines (Human Development
Department), Department for International Development
Panel 2. The Ethics of Evidence: Challenges Related to Treatment in Low-Income
Countries
Chair: Dr Gail Davey, Brighton and Sussex Medical School
Discussant: Dr Dermot Maher, Wellcome Trust
Speakers:
Dr Adamu Addissie, School of Public Health, Addis Ababa University, Ethiopia
Dr Trudie Lang, Centre for Tropical Medicine, University of Oxford
Professor Melanie Newport, Brighton and Sussex Medical School
Professor Bobbie Farsides, Brighton and Sussex Medical School
Professor Melanie Newport, Brighton and Sussex Medical School
2
Panel 3. Designing Pharmaceutical Markets: Pharmaceuticalisation, Regulation
and Global Health
Chair: Dr Catherine Will, University of Sussex
Discussant: Professor Melissa Leach, Institute of Development Studies
Speakers:
Dr Gerry Bloom, Institute of Development Studies
Dr Ian Harper, Department of Anthropology, University of Edinburgh
Dr Alex Faulkner, Centre for Global Health Policy, University of Sussex
Professor Paul Martin, University of Sheffield
Professor John Abraham, King’s College London
3:15 – 3:45
Tea break
3:45 – 5:15
Concurrent Panel Session:
Panel 4. The Price of Life: Intellectual Property, Patents and Standards in Global
Health
Chair: Professor Brian Salter, King’s College London
Discussant: Dr Sophie Harman, Queen Mary, University of London
Speakers:
Dr Peter Bogner, President, The GISAID Initiative
Dr Charles Clift, Centre on Global Health Security, Chatham House
Dr Phoebe Li, University of Sussex
Dr Ken Shadlen, London School of Economics
Panel 5. Medical Countermeasures: Pharmaceuticals, Antimicrobial Resistance
and Global Health Security
Chair: Professor Stefan Elbe, Director, Centre for Global Health Policy
Discussant: Professor Jon Cohen, Brighton & Sussex Medical School
3
Speakers:
Professor Anthony Kessel, Director of Public Health Strategy, Health Protection
Agency
Dr Paul Russel, Defence, Science and Technology Laboratory
Professor Jonathan Van Tam, Leader, Health Protection Research Group, University
of Nottingham
Dr Adam Kamradt-Scott, Centre for International Security Studies, University of
Sydney
Panel 6. Pharmaceutical Selves: Drugs, Research Subjects and Patients in Global
Health
Chair: Dr David Reubi, School of Geography, Queen Mary, University of London
Discussant: Professor Peter Aggleton, National Centre in HIV Social Research,
University of New South Wales
Speakers:
Dr Catherine Montgomery, Institute for Science, Innovation and Society (InSIS),
University of Oxford
Professor Margaret Sleeboom-Faulkner, Director, Centre for Bionetworking,
University of Sussex
Dr Hakan Seckinelgin, Department of Social Policy, London School of Economics
Dr Alice Street, School of Social and Political Science, University of Edinburgh
Dr Kathryn Jones, Health Policy Research Unit, De Montfort University
5:15 – 5:30
Closing Comments
5:30 – 6:30
Wine Reception
6:30
End of conference
4